{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:15:42Z","timestamp":1791918942827,"version":"4.3.4"},"reference-count":178,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:00:00Z","timestamp":1669334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>The glymphatic system is a unique pathway that utilises end-feet Aquaporin 4 (AQP4) channels within perivascular astrocytes, which is believed to cause cerebrospinal fluid (CSF) inflow into perivascular space (PVS), providing nutrients and waste disposal of the brain parenchyma. It is theorised that the bulk flow of CSF within the PVS removes waste products, soluble proteins, and products of metabolic activity, such as amyloid-\u03b2 (A\u03b2). In the experimental model, the glymphatic system is selectively active during slow-wave sleep, and its activity is affected by both sleep dysfunction and deprivation. Dysfunction of the glymphatic system has been proposed as a potential key driver of neurodegeneration. This hypothesis is indirectly supported by the close relationship between neurodegenerative diseases and sleep alterations, frequently occurring years before the clinical diagnosis. Therefore, a detailed characterisation of the function of the glymphatic system in human physiology and disease would shed light on its early stage pathophysiology. The study of the glymphatic system is also critical to identifying means for its pharmacological modulation, which may have the potential for disease modification. This review will critically outline the primary evidence from literature about the dysfunction of the glymphatic system in neurodegeneration and discuss the rationale and current knowledge about pharmacological modulation of the glymphatic system in the animal model and its potential clinical applications in human clinical trials.<\/jats:p>","DOI":"10.3390\/jcm11236964","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T06:04:36Z","timestamp":1669615476000},"page":"6964","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Research Evidence of the Role of the Glymphatic System and Its Potential Pharmacological Modulation in Neurodegenerative Diseases"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6651-9994","authenticated-orcid":false,"given":"Joji Philip","family":"Verghese","sequence":"first","affiliation":[{"name":"Neurodegeneration Imaging Group, University of Exeter Medical School, London W12 0BZ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alana","family":"Terry","sequence":"additional","affiliation":[{"name":"Neurodegeneration Imaging Group, University of Exeter Medical School, London W12 0BZ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo Rosario","family":"de Natale","sequence":"additional","affiliation":[{"name":"Neurodegeneration Imaging Group, University of Exeter Medical School, London W12 0BZ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios","family":"Politis","sequence":"additional","affiliation":[{"name":"Neurodegeneration Imaging Group, University of Exeter Medical School, London W12 0BZ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1007\/s11064-015-1581-6","article-title":"The Glymphatic System: A Beginner\u2019s Guide","volume":"40","author":"Jessen","year":"2015","journal-title":"Neurochem. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"7698","DOI":"10.1523\/JNEUROSCI.0619-21.2021","article-title":"The Glymphatic System: A Novel Component of Fundamental Neurobiology","volume":"41","author":"Hablitz","year":"2021","journal-title":"J. Neurosci."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Natale, G., Limanaqi, F., Busceti, C.L., Mastroiacovo, F., Nicoletti, F., Puglisi-Allegra, S., and Fornai, F. (2021). Glymphatic System as a Gateway to Connect Neurodegeneration From Periphery to CNS. Front. Neurosci., 15.","DOI":"10.3389\/fnins.2021.639140"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00401-018-1812-4","article-title":"The role of brain barriers in fluid movement in the CNS: Is there a \u2018glymphatic\u2019 system?","volume":"135","author":"Abbott","year":"2018","journal-title":"Acta Neuropathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","article-title":"A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2","volume":"4","author":"Iliff","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1161\/STROKEAHA.112.678698","article-title":"Is there a cerebral lymphatic system?","volume":"44","author":"Iliff","year":"2013","journal-title":"Stroke"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1002\/jnr.24718","article-title":"Locus Coeruleus and neurovascular unit: From its role in physiology to its potential role in Alzheimer\u2019s disease pathogenesis","volume":"98","author":"Giorgi","year":"2020","journal-title":"J. Neurosci. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1177\/0271678X15622047","article-title":"Ultra-fast magnetic resonance encephalography of physiological brain activity - Glymphatic pulsation mechanisms?","volume":"36","author":"Kiviniemi","year":"2016","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1126\/science.abb8739","article-title":"Glymphatic failure as a final common pathway to dementia","volume":"370","author":"Nedergaard","year":"2020","journal-title":"Science"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1241224","article-title":"Sleep drives metabolite clearance from the adult brain","volume":"342","author":"Xie","year":"2013","journal-title":"Science"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Reddy, O.C., and van der Werf, Y.D. (2020). The Sleeping Brain: Harnessing the Power of the Glymphatic System through Lifestyle Choices. Brain Sci., 10.","DOI":"10.3390\/brainsci10110868"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1073\/pnas.1721694115","article-title":"\u03b2-Amyloid accumulation in the human brain after one night of sleep deprivation","volume":"115","author":"Wang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s13760-016-0639-9","article-title":"Amyloid beta plaque: A culprit for neurodegeneration","volume":"116","author":"Gupta","year":"2016","journal-title":"Acta Neurol. Belg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/ana.24271","article-title":"Impairment of paravascular clearance pathways in the aging brain","volume":"76","author":"Kress","year":"2014","journal-title":"Ann. Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s42466-021-00102-7","article-title":"Glymphatic system, AQP4, and their implications in Alzheimer\u2019s disease","volume":"3","author":"Silva","year":"2021","journal-title":"Neurol. Res. Pract."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.exger.2008.12.004","article-title":"Age-related changes in choroid plexus and blood-cerebrospinal fluid barrier function in the sheep","volume":"44","author":"Chen","year":"2009","journal-title":"Exp. Gerontol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Fleischman, D., Berdahl, J.P., Zaydlarova, J., Stinnett, S., Fautsch, M.P., and Allingham, R.R. (2012). Cerebrospinal fluid pressure decreases with older age. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0052664"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/01.ATV.0000160548.78317.29","article-title":"Mechanisms, pathophysiology, and therapy of arterial stiffness","volume":"25","author":"Zieman","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"18190","DOI":"10.1523\/JNEUROSCI.1592-13.2013","article-title":"Cerebral arterial pulsation drives paravascular CSF-interstitial fluid exchange in the murine brain","volume":"33","author":"Iliff","year":"2013","journal-title":"J. Neurosci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3389\/fnagi.2021.689098","article-title":"The Glymphatic System: A Novel Therapeutic Target for Stroke Treatment","volume":"13","author":"Lv","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.31887\/DCNS.2000.2.2\/asschachter","article-title":"Alzheimer\u2019s disease","volume":"2","author":"Schachter","year":"2000","journal-title":"Dialogues Clin. Neurosci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/msj.20157","article-title":"Neuropathology of Alzheimer\u2019s disease","volume":"77","author":"Perl","year":"2010","journal-title":"Mt. Sinai J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Chen, Y.-X., Liang, N., Li, X.-L., Yang, S.-H., Wang, Y.-P., and Shi, N.-N. (2021). Diagnosis and Treatment for Mild Cognitive Impairment: A Systematic Review of Clinical Practice Guidelines and Consensus Statements. Front. Neurol., 12.","DOI":"10.3389\/fneur.2021.719849"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3233\/JAD-160979","article-title":"The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations","volume":"56","author":"Ismail","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1590\/S1980-5764-2016DN1003002","article-title":"Subjective cognitive decline: The first clinical manifestation of Alzheimer\u2019s disease?","volume":"10","author":"Studart","year":"2016","journal-title":"Dement Neuropsychol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s13311-014-0324-8","article-title":"Targeting the prodromal stage of Alzheimer\u2019s disease: Bioenergetic and mitochondrial opportunities","volume":"12","author":"Caldwell","year":"2015","journal-title":"Neurotherapeutics"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.sleep.2004.12.005","article-title":"Sleep disturbance in mild to moderate Alzheimer\u2019s disease","volume":"6","author":"Moran","year":"2005","journal-title":"Sleep Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrneurol.2013.269","article-title":"Sleep and Alzheimer disease pathology\u2014A bidirectional relationship","volume":"10","author":"Ju","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"551","DOI":"10.32794\/mr112500111","article-title":"Neural glymphatic system: Clinical implications and potential importance of melatonin","volume":"4","author":"Bitar","year":"2021","journal-title":"Melatonin Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: Progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","article-title":"Clearance systems in the brain-implications for Alzheimer disease","volume":"11","author":"Carare","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.2967\/jnumed.118.223834","article-title":"Dynamic (11)C-PiB PET Shows Cerebrospinal Fluid Flow Alterations in Alzheimer Disease and Multiple Sclerosis","volume":"60","author":"Schubert","year":"2019","journal-title":"J. Nucl. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.molmed.2019.11.008","article-title":"Glymphatic System Impairment in Alzheimer\u2019s Disease and Idiopathic Normal Pressure Hydrocephalus","volume":"26","author":"Reeves","year":"2020","journal-title":"Trends Mol. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1212\/01.wnl.0000435301.64776.37","article-title":"Pulse wave velocity is associated with \u03b2-amyloid deposition in the brains of very elderly adults","volume":"81","author":"Hughes","year":"2013","journal-title":"Neurology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.nbd.2016.05.015","article-title":"Suppression of glymphatic fluid transport in a mouse model of Alzheimer\u2019s disease","volume":"93","author":"Peng","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13195-020-00688-1","article-title":"Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer\u2019s disease mouse model with suppression of glymphatic clearance","volume":"12","author":"Feng","year":"2020","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.bbagen.2013.09.033","article-title":"Human aquaporins: Regulators of transcellular water flow","volume":"1840","author":"Day","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000490349","article-title":"The Glymphatic System and Waste Clearance with Brain Aging: A Review","volume":"65","author":"Benveniste","year":"2019","journal-title":"Gerontology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00213-016-4473-9","article-title":"Mechanism of depression as a risk factor in the development of Alzheimer\u2019s disease: The function of AQP4 and the glymphatic system","volume":"234","author":"Xia","year":"2017","journal-title":"Psychopharmacology"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Mestre, H., Hablitz, L.M., Xavier, A.L., Feng, W., Zou, W., Pu, T., Monai, H., Murlidharan, G., Castellanos Rivera, R.M., and Simon, M.J. (2018). Aquaporin-4-dependent glymphatic solute transport in the rodent brain. Elife, 7.","DOI":"10.7554\/eLife.40070"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.14336\/AD.2021.0731","article-title":"Aquaporin-4 and Cognitive Disorders","volume":"13","author":"Wang","year":"2022","journal-title":"Aging Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3233\/JAD-150949","article-title":"Aquaporin-4 and Alzheimer\u2019s Disease","volume":"52","author":"Yang","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3233\/JAD-2011-110725","article-title":"Loss of astrocyte polarization in the tg-ArcSwe mouse model of Alzheimer\u2019s disease","volume":"27","author":"Yang","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/jamaneurol.2016.4370","article-title":"Association of Perivascular Localization of Aquaporin-4 With Cognition and Alzheimer Disease in Aging Brains","volume":"74","author":"Zeppenfeld","year":"2017","journal-title":"JAMA Neurol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Mader, S., and Brimberg, L. (2019). Aquaporin-4 Water Channel in the Brain and Its Implication for Health and Disease. Cells, 8.","DOI":"10.3390\/cells8020090"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13024-015-0056-1","article-title":"Deletion of aquaporin-4 in APP\/PS1 mice exacerbates brain A\u03b2 accumulation and memory deficits","volume":"10","author":"Xu","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2020.06.007","article-title":"Aquaporin-4 polymorphisms predict amyloid burden and clinical outcome in the Alzheimer\u2019s disease spectrum","volume":"97","author":"Chandra","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson\u2019s disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson\u2019s disease: Clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"J. Neural. Transm."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3233\/JPD-191627","article-title":"Sleep Disturbance as Potential Risk and Progression Factor for Parkinson\u2019s Disease","volume":"9","author":"Bohnen","year":"2019","journal-title":"J. Parkinsons Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/aje\/kwj096","article-title":"A prospective study of night shift work, sleep duration, and risk of Parkinson\u2019s disease","volume":"163","author":"Chen","year":"2006","journal-title":"Am. J. Epidemiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/jsr.12545","article-title":"Sleep disorders and an increased risk of Parkinson\u2019s disease in individuals with non-apnea sleep disorders: A population-based cohort study","volume":"26","author":"Hsiao","year":"2017","journal-title":"J. Sleep Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/sleep\/25.2.120","article-title":"REM sleep behavior disorder: Clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP","volume":"25","author":"Schenck","year":"2002","journal-title":"Sleep"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/mds.27018","article-title":"REM Sleep Behavior Disorder in Parkinson\u2019s Disease and Other Synucleinopathies","volume":"32","author":"Boeve","year":"2017","journal-title":"Mov. Disord."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/mds.22242","article-title":"The prodromal phase of sporadic Parkinson\u2019s disease: Does it exist and if so how long is it?","volume":"23","author":"Hawkes","year":"2008","journal-title":"Mov. Disord."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3233\/JPD-130293","article-title":"Clinical implication of REM sleep behavior disorder in Parkinson\u2019s disease","volume":"4","author":"Kim","year":"2014","journal-title":"J. Parkinsons Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/brain\/awz030","article-title":"Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: A multicentre study","volume":"142","author":"Postuma","year":"2019","journal-title":"Brain"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Baumann-Vogel, H., Hor, H., Poryazova, R., Valko, P., Werth, E., and Baumann, C.R. (2020). REM sleep behavior in Parkinson disease: Frequent, particularly with higher age. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0243454"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/mds.24939","article-title":"Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson\u2019s disease: A prospective study","volume":"27","author":"Postuma","year":"2012","journal-title":"Mov. Disord."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.sleep.2005.03.011","article-title":"Progressive sleep \u2019destructuring\u2019 in Parkinson\u2019s disease. A polysomnographic study in 46 patients","volume":"6","author":"Diederich","year":"2005","journal-title":"Sleep Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1474-9726.2011.00677.x","article-title":"Novel role of aquaporin-4 in CD4+ CD25+ T regulatory cell development and severity of Parkinson\u2019s disease","volume":"10","author":"Chi","year":"2011","journal-title":"Aging Cell"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neuroscience.2016.01.003","article-title":"Aquaporin-4 mediates communication between astrocyte and microglia: Implications of neuroinflammation in experimental Parkinson\u2019s disease","volume":"317","author":"Sun","year":"2016","journal-title":"Neuroscience"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1111\/jcmm.14147","article-title":"Aquaporin-4 deficiency reduces TGF-\u03b21 in mouse midbrains and exacerbates pathology in experimental Parkinson\u2019s disease","volume":"23","author":"Xue","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neulet.2015.12.057","article-title":"Aquaporin-4 deficiency diminishes the differential degeneration of midbrain dopaminergic neurons in experimental Parkinson\u2019s disease","volume":"614","author":"Zhang","year":"2016","journal-title":"Neurosci. Lett."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1007\/s12031-021-01836-4","article-title":"Decreased AQP4 Expression Aggravates \u0251-Synuclein Pathology in Parkinson\u2019s Disease Mice, Possibly via Impaired Glymphatic Clearance","volume":"71","author":"Cui","year":"2021","journal-title":"J. Mol. Neurosci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/bpa.12369","article-title":"Expression of Aquaporin 1 and Aquaporin 4 in the Temporal Neocortex of Patients with Parkinson\u2019s Disease","volume":"27","author":"Hoshi","year":"2017","journal-title":"Brain Pathol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"760518","DOI":"10.3389\/fneur.2021.760518","article-title":"Quantification of Brain \u03b2-Amyloid Load in Parkinson\u2019s Disease With Mild Cognitive Impairment: A PET\/MRI Study","volume":"12","author":"Garon","year":"2021","journal-title":"Front. Neurol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.parkreldis.2022.01.002","article-title":"Perivascular space in Parkinson\u2019s disease: Association with CSF amyloid\/tau and cognitive decline","volume":"95","author":"Chen","year":"2022","journal-title":"Parkinsonism. Relat. Disord."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000464322","article-title":"Extremely Low Prevalence of Amyloid Positron Emission Tomography Positivity in Parkinson\u2019s Disease without Dementia","volume":"77","author":"Mashima","year":"2017","journal-title":"Eur. Neurol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3389\/fneur.2019.00391","article-title":"Beta Amyloid Deposition Is Not Associated With Cognitive Impairment in Parkinson\u2019s Disease","volume":"10","author":"Melzer","year":"2019","journal-title":"Front. Neurol."},{"key":"ref_74","unstructured":"Hodgson, E., Roe, R.M., Mailman, R.B., and Chambers, J.E. (2015). Dictionary of Toxicology, Academic Press. [3rd ed.]."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"135256","DOI":"10.1016\/j.neulet.2020.135256","article-title":"APOE rs405509 polymorphism and Parkinson\u2019s disease risk in the Chinese population","volume":"736","author":"Huang","year":"2020","journal-title":"Neurosci. Lett."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Kim, H., Nanavaty, N., Ahmed, H., Mathur, V.A., and Anderson, B.A. (2021). Motivational Salience Guides Attention to Valuable and Threatening Stimuli: Evidence from Behavior and Functional Magnetic Resonance Imaging. J. Cogn. Neurosci.","DOI":"10.31234\/osf.io\/adxwy"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"559","DOI":"10.5603\/PJNNS.a2021.0071","article-title":"Effects of sex and APOE on Parkinson\u2019s Disease-related cognitive decline","volume":"55","author":"Tipton","year":"2021","journal-title":"Neurol. I Neurochir. Pol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.ajpath.2011.07.021","article-title":"Apolipoprotein E and LRP1 Increase Early in Parkinson\u2019s Disease Pathogenesis","volume":"179","author":"Wilhelmus","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"870029","DOI":"10.3389\/fimmu.2022.870029","article-title":"Acutely Inhibiting AQP4 With TGN-020 Improves Functional Outcome by Attenuating Edema and Peri-Infarct Astrogliosis After Cerebral Ischemia","volume":"13","author":"Sun","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ene.13413","article-title":"Huntington\u2019s disease: A clinical review","volume":"25","author":"McColgan","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/practneurol-2021-003074","article-title":"Huntington\u2019s disease: Diagnosis and management","volume":"22","author":"Stoker","year":"2022","journal-title":"Pract. Neurol."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"de la Cruz, J., and Hwang, J. (2021). On the hunt for a cure: A guide to Huntington disease. JAAPA, 34.","DOI":"10.1097\/01.JAA.0000735740.95438.60"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2217\/fnl-2017-0035","article-title":"New directions in therapeutics for Huntington disease","volume":"13","author":"Potkin","year":"2018","journal-title":"Future Neurol."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Herzog\u2013Krzywoszanska, R., and Krzywoszanski, L. (2019). Sleep Disorders in Huntington\u2019s Disease. Front. Psychiatry, 10.","DOI":"10.3389\/fpsyt.2019.00221"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1523\/JNEUROSCI.1865-20.2020","article-title":"Mutant Huntingtin Is Cleared from the Brain via Active Mechanisms in Huntington Disease","volume":"41","author":"Caron","year":"2021","journal-title":"J. Neurosci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1172\/JCI80743","article-title":"Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington\u2019s disease patients","volume":"125","author":"Wild","year":"2015","journal-title":"J. Clin. Invest."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.amjmed.2018.07.012","article-title":"Motor Neuron Disease: Pathophysiology, Diagnosis, and Management","volume":"132","author":"Foster","year":"2019","journal-title":"Am. J. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Kiernan","year":"2011","journal-title":"Lancet"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ar.20838","article-title":"Aquaporin-4 overexpression in rat ALS model","volume":"292","author":"Nicaise","year":"2009","journal-title":"Anat. Rec."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1002\/glia.22414","article-title":"Changes in the astrocytic aquaporin-4 and inwardly rectifying potassium channel expression in the brain of the amyotrophic lateral sclerosis SOD1(G93A) rat model","volume":"60","author":"Andjus","year":"2012","journal-title":"Glia"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.3892\/mmr.2017.6786","article-title":"Alterations in AQP4 expression and polarization in the course of motor neuron degeneration in SOD1G93A mice","volume":"16","author":"Dai","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1742-2094-11-42","article-title":"Extensive dysregulations of oligodendrocytic and astrocytic connexins are associated with disease progression in an amyotrophic lateral sclerosis mouse model","volume":"11","author":"Cui","year":"2014","journal-title":"J. Neuroinflamm."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s10072-019-03877-5","article-title":"The potential roles of aquaporin 4 in amyotrophic lateral sclerosis","volume":"40","author":"Zou","year":"2019","journal-title":"Neurol. Sci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1471-4159.2005.03362.x","article-title":"Aquaporin-4 gene deletion in mice increases focal edema associated with staphylococcal brain abscess","volume":"95","author":"Bloch","year":"2005","journal-title":"J. Neurochem."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/sj.jcbfm.9600306","article-title":"Accelerated progression of kaolin-induced hydrocephalus in aquaporin-4-deficient mice","volume":"26","author":"Bloch","year":"2006","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/WNR.0b013e3282f2b4eb","article-title":"Altered blood-brain barrier integrity in adult aquaporin-4 knockout mice","volume":"19","author":"Zhou","year":"2008","journal-title":"Neuroreport"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Li, L., Zhang, H., and Verkman, A.S. (2009). Greatly attenuated experimental autoimmune encephalomyelitis in aquaporin-4 knockout mice. BMC Neurosci., 10.","DOI":"10.1186\/1471-2202-10-94"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neulet.2014.03.073","article-title":"Neuroprotective effect of aquaporin-4 deficiency in a mouse model of severe global cerebral ischemia produced by transient 4-vessel occlusion","volume":"574","author":"Akdemir","year":"2014","journal-title":"Neurosci. Lett."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neures.2017.11.001","article-title":"Dissociation of blood-brain barrier disruption and disease manifestation in an aquaporin-4-deficient mouse model of amyotrophic lateral sclerosis","volume":"133","author":"Moriwaki","year":"2018","journal-title":"Neurosci. Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2333721416643702","DOI":"10.1177\/2333721416643702","article-title":"Idiopathic Normal Pressure Hydrocephalus: A Review for General Practitioners","volume":"2","author":"Nassar","year":"2016","journal-title":"Gerontol. Geriatr. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/ncpneuro0237","article-title":"The diagnosis and treatment of idiopathic normal pressure hydrocephalus","volume":"2","author":"Gallia","year":"2006","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.wneu.2015.10.069","article-title":"Incidence of Idiopathic Normal-Pressure Hydrocephalus in Northern Spain","volume":"87","year":"2016","journal-title":"World Neurosurg."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2147\/CIA.S290709","article-title":"The Pathogenesis Based on the Glymphatic System, Diagnosis, and Treatment of Idiopathic Normal Pressure Hydrocephalus","volume":"16","author":"Tan","year":"2021","journal-title":"Clin. Interv. Aging"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Tang, Y.-m., Yao, Y., Xu, S., Li, X., Hu, F., Wang, H., Ding, J., and Wang, X. (2021). White Matter Microstructural Damage Associated With Gait Abnormalities in Idiopathic Normal Pressure Hydrocephalus. Front. Aging Neurosci., 13.","DOI":"10.3389\/fnagi.2021.660621"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1093\/brain\/awx191","article-title":"Glymphatic MRI in idiopathic normal pressure hydrocephalus","volume":"140","author":"Ringstad","year":"2017","journal-title":"Brain"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1177\/0271678X18760974","article-title":"Delayed clearance of cerebrospinal fluid tracer from entorhinal cortex in idiopathic normal pressure hydrocephalus: A glymphatic magnetic resonance imaging study","volume":"39","author":"Eide","year":"2019","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/nan.12420","article-title":"Astrogliosis and impaired aquaporin-4 and dystrophin systems in idiopathic normal pressure hydrocephalus","volume":"44","author":"Eide","year":"2018","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/glia.23528","article-title":"Loss of perivascular aquaporin-4 in idiopathic normal pressure hydrocephalus","volume":"67","author":"Enger","year":"2019","journal-title":"Glia"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-3-319-22533-3_57","article-title":"Disproportionately Enlarged Subarachnoid Space Hydrocephalus in Idiopathic Normal-Pressure Hydrocephalus and Its Implication in Pathogenesis","volume":"122","author":"Ishikawa","year":"2016","journal-title":"Acta Neurochir. Suppl."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jocn.2018.10.147","article-title":"Pathogenesis of idiopathic Normal Pressure Hydrocephalus: A review of knowledge","volume":"61","author":"Vakis","year":"2019","journal-title":"J. Clin. Neurosci."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3233\/JAD-190775","article-title":"Two-Point Dynamic Observation of Alzheimer\u2019s Disease Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus","volume":"72","author":"Jingami","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.ncl.2016.06.016","article-title":"Epidemiology of Multiple Sclerosis","volume":"34","author":"Howard","year":"2016","journal-title":"Neurol. Clin."},{"key":"ref_113","first-page":"529","article-title":"Multiple Sclerosis: An Update","volume":"87","author":"Faguy","year":"2016","journal-title":"Radiol. Technol."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Rohr, S.O., Greiner, T., Joost, S., Amor, S., Valk, P.V., Schmitz, C., and Kipp, M. (2020). Aquaporin-4 Expression during Toxic and Autoimmune Demyelination. Cells, 9.","DOI":"10.3390\/cells9102187"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00401-003-0709-y","article-title":"Enhanced expression of aquaporin 4 in human brain with infarction","volume":"106","author":"Aoki","year":"2003","journal-title":"Acta Neuropathol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00401-005-1052-2","article-title":"Enhanced expression of aquaporin 4 in human brain with inflammatory diseases","volume":"110","author":"Uchihara","year":"2005","journal-title":"Acta Neuropathol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.nbd.2005.06.012","article-title":"Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis","volume":"20","author":"Vos","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"ref_118","unstructured":"Carotenuto, A., Cacciaguerra, L., Pagani, E., Preziosa, P., Filippi, M., and Rocca, M.A. (1093). Glymphatic system impairment in multiple sclerosis: Relation with brain damage and disability. Brain."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/B978-0-444-63521-1.00037-6","article-title":"Chapter 37 - Traumatic brain injury and cognition","volume":"Volume 128","author":"Grafman","year":"2015","journal-title":"Handbook of Clinical Neurology"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Ng, S.Y., and Lee, A.Y.W. (2019). Traumatic Brain Injuries: Pathophysiology and Potential Therapeutic Targets. Front. Cell. Neurosci., 13.","DOI":"10.3389\/fncel.2019.00528"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neubiorev.2021.11.036","article-title":"Blood-based biomarkers of inflammation in mild traumatic brain injury: A systematic review","volume":"132","author":"Visser","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrn2808","article-title":"Traumatic brain injury and amyloid-\u03b2 pathology: A link to Alzheimer\u2019s disease?","volume":"11","author":"Johnson","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1089\/neu.2017.5042","article-title":"Repeat Mild Traumatic Brain Injury in Adolescent Rats Increases Subsequent \u03b2-Amyloid Pathogenesis","volume":"35","author":"Grant","year":"2017","journal-title":"J. Neurotrauma"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.neuron.2012.11.021","article-title":"The neuropathology and neurobiology of traumatic brain injury","volume":"76","author":"Blennow","year":"2012","journal-title":"Neuron"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"6254","DOI":"10.1038\/s41598-020-63022-7","article-title":"Repetitive Mild Traumatic Brain Injury Alters Glymphatic Clearance Rates in Limbic Structures of Adolescent Female Rats","volume":"10","author":"Christensen","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"16180","DOI":"10.1523\/JNEUROSCI.3020-14.2014","article-title":"Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury","volume":"34","author":"Iliff","year":"2014","journal-title":"J. Neurosci."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"147062","DOI":"10.1016\/j.brainres.2020.147062","article-title":"MRI detection of impairment of glymphatic function in rat after mild traumatic brain injury","volume":"1747","author":"Li","year":"2020","journal-title":"Brain Res."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.neubiorev.2017.08.016","article-title":"Glymphatic system disruption as a mediator of brain trauma and chronic traumatic encephalopathy","volume":"84","author":"Sullan","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S1474-4422(18)30318-1","article-title":"The glymphatic pathway in neurological disorders","volume":"17","author":"Rasmussen","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1212\/01.wnl.0000801968.87371.4e","article-title":"Glymphatic System Dysfunction in Mild Traumatic Brain Injury","volume":"98","author":"Doustar","year":"2022","journal-title":"Neurology"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41573-022-00500-9","article-title":"The glymphatic system: Implications for drugs for central nervous system diseases","volume":"21","author":"Lohela","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainresbull.2018.10.007","article-title":"Deletion of aquaporin-4 aggravates brain pathology after blocking of the meningeal lymphatic drainage","volume":"143","author":"Cao","year":"2018","journal-title":"Brain Res. Bull."},{"key":"ref_133","first-page":"4948","article-title":"Aquaporin 4 in Astrocytes is a Target for Therapy in Alzheimer\u2019s Disease","volume":"23","author":"Lan","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"113685","DOI":"10.1016\/j.expneurol.2021.113685","article-title":"The role of glymphatic system in the cerebral edema formation after ischemic stroke","volume":"340","author":"Ji","year":"2021","journal-title":"Exp. Neurol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/WNR.0000000000000990","article-title":"Aquaporin-4 facilitator TGN-073 promotes interstitial fluid circulation within the blood-brain barrier: [17O]H2O JJVCPE MRI study","volume":"29","author":"Huber","year":"2018","journal-title":"Neuroreport"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.bmc.2007.12.040","article-title":"Identification of Aquaporin 4 inhibitors using in vitro and in silico methods","volume":"17","author":"Huber","year":"2009","journal-title":"Bioorganic Med. Chem."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Pirici, I., Balsanu, T.A., Bogdan, C., Margaritescu, C., Divan, T., Vitalie, V., Mogoanta, L., Pirici, D., Carare, R.O., and Muresanu, D.F. (2017). Inhibition of Aquaporin-4 Improves the Outcome of Ischaemic Stroke and Modulates Brain Paravascular Drainage Pathways. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19010046"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1124\/mol.108.053744","article-title":"Inhibition of aquaporin-1 and aquaporin-4 water permeability by a derivative of the loop diuretic bumetanide acting at an internal pore-occluding binding site","volume":"76","author":"Migliati","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.bmc.2007.12.038","article-title":"Inhibition of aquaporin 4 by antiepileptic drugs","volume":"17","author":"Huber","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"7489","DOI":"10.1016\/j.bmc.2008.06.005","article-title":"Lack of aquaporin-4 water transport inhibition by antiepileptics and arylsulfonamides","volume":"16","author":"Yang","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"14207","DOI":"10.1074\/jbc.M513072200","article-title":"Quaternary ammonium compounds as water channel blockers. Specificity, potency, and site of action","volume":"281","author":"Detmers","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1080\/14728222.2021.2010045","article-title":"Emerging therapeutic targets for cerebral edema","volume":"25","author":"Jha","year":"2021","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1759091420960550","DOI":"10.1177\/1759091420960550","article-title":"Alleviation of Cerebral Infarction of Rats With Middle Cerebral Artery Occlusion by Inhibition of Aquaporin 4 in the Supraoptic Nucleus","volume":"12","author":"Cui","year":"2020","journal-title":"ASN Neuro."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1089\/neu.2019.6653","article-title":"Vasopressin V(1a) Receptors Regulate Cerebral Aquaporin 1 after Traumatic Brain Injury","volume":"37","author":"Rauen","year":"2020","journal-title":"J. Neurotrauma"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: In vivo veritas","volume":"122","author":"Sica","year":"2012","journal-title":"J. Clin. Invest."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Taya, K., Gulsen, S., Okuno, K., Prieto, R., Marmarou, C.R., and Marmarou, A. (2009). Modulation of AQP4 expression by the selective V1a receptor antagonist, SR49059, decreases trauma-induced brain edema. Acta Neurochirurgica Supplements, Springer.","DOI":"10.1007\/978-3-211-85578-2_83"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.brainres.2014.03.005","article-title":"Minocycline mitigates motor impairments and cortical neuronal loss induced by focal ischemia in rats chronically exposed to ethanol during adolescence","volume":"1561","author":"Oliveira","year":"2014","journal-title":"Brain Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1210\/en.2006-1276","article-title":"Modest thyroid hormone insufficiency during development induces a cellular malformation in the corpus callosum: A model of cortical dysplasia","volume":"148","author":"Goodman","year":"2007","journal-title":"Endocrinology"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3389\/fnins.2019.00317","article-title":"Evidence of Aquaporin 4 Regulation by Thyroid Hormone During Mouse Brain Development and in Cultured Human Glioblastoma Multiforme Cells","volume":"13","author":"Costa","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jns.2015.04.042","article-title":"Anti-edema action of thyroid hormone in MCAO model of ischemic brain stroke: Possible association with AQP4 modulation","volume":"354","author":"Sadana","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Vandebroek, A., and Yasui, M. (2020). Regulation of AQP4 in the Central Nervous System. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21051603"},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Cardinali, D.P. (2019). Melatonin: Clinical Perspectives in Neurodegeneration. Front. Endocrinol., 10.","DOI":"10.3389\/fendo.2019.00480"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"110887","DOI":"10.1016\/j.biopha.2020.110887","article-title":"Melatonin regulates A\u03b2 production\/clearance balance and A\u03b2 neurotoxicity: A potential therapeutic molecule for Alzheimer\u2019s disease","volume":"132","author":"Li","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2174\/1570159X14666161228122115","article-title":"Melatonin: Pharmacology, Functions and Therapeutic Benefits","volume":"15","author":"Tordjman","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2174\/1567205015666180411092551","article-title":"Melatonin Treatment Enhances A\u03b2 Lymphatic Clearance in a Transgenic Mouse Model of Amyloidosis","volume":"15","author":"Pappolla","year":"2018","journal-title":"Curr. Alzheimer. Res."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"659457","DOI":"10.3389\/fnagi.2021.659457","article-title":"Dysfunction of the Glymphatic System as a Potential Mechanism of Perioperative Neurocognitive Disorders","volume":"13","author":"Ren","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"eaav5447","DOI":"10.1126\/sciadv.aav5447","article-title":"Increased glymphatic influx is correlated with high EEG delta power and low heart rate in mice under anesthesia","volume":"5","author":"Hablitz","year":"2019","journal-title":"Sci. Adv."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neulet.2013.02.022","article-title":"\u03b12-Adrenergic agonists including xylazine and dexmedetomidine inhibit norepinephrine transporter function in SK-N-SH cells","volume":"541","author":"Park","year":"2013","journal-title":"Neurosci. Lett."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1146\/annurev-pathol-051217-111018","article-title":"The Glymphatic System in Central Nervous System Health and Disease: Past, Present, and Future","volume":"13","author":"Plog","year":"2018","journal-title":"Annu. Rev. Pathol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s11427-019-1633-3","article-title":"Brain interstitial fluid drainage and extracellular space affected by inhalational isoflurane: In comparison with intravenous sedative dexmedetomidine and pentobarbital sodium","volume":"63","author":"Zhao","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s13311-019-00769-6","article-title":"Sleep as a Therapeutic Target in the Aging Brain","volume":"16","author":"Bah","year":"2019","journal-title":"Neurotherapeutics"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2019.05.005","article-title":"Dexmedetomidine enhances glymphatic brain delivery of intrathecally administered drugs","volume":"304","author":"Lilius","year":"2019","journal-title":"J. Control. Release"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4103\/0259-1162.94750","article-title":"Current role of dexmedetomidine in clinical anesthesia and intensive care","volume":"5","author":"Kaur","year":"2011","journal-title":"Anesth. Essays Res."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.tips.2022.09.007","article-title":"Could dexmedetomidine be repurposed as a glymphatic enhancer?","volume":"43","author":"Persson","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Semyachkina-Glushkovskaya, O., Postnov, D., Penzel, T., and Kurths, J. (2020). Sleep as a Novel Biomarker and a Promising Therapeutic Target for Cerebral Small Vessel Disease: A Review Focusing on Alzheimer\u2019s Disease and the Blood-Brain Barrier. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176293"},{"key":"ref_166","first-page":"100025","article-title":"Aberrant waste disposal in neurodegeneration: Why improved sleep could be the solution","volume":"2","author":"Wafford","year":"2021","journal-title":"Cerebral. Circ. Cogn. Behav."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"eaau6550","DOI":"10.1126\/scitranslmed.aau6550","article-title":"Reduced non-rapid eye movement sleep is associated with tau pathology in early Alzheimer\u2019s disease","volume":"11","author":"Lucey","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/sleep\/33.9.1217","article-title":"Enhancing Slow Wave Sleep with Sodium Oxybate Reduces the Behavioral and Physiological Impact of Sleep Loss","volume":"33","author":"Walsh","year":"2010","journal-title":"Sleep"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3389\/fnins.2020.00705","article-title":"Slow Wave Sleep Is a Promising Intervention Target for Alzheimer\u2019s Disease","volume":"14","author":"Lee","year":"2020","journal-title":"Front. Neurosci."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3389\/fnins.2019.00740","article-title":"Gating and the Need for Sleep: Dissociable Effects of Adenosine A1 and A2A Receptors","volume":"13","author":"Lazarus","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5334\/jcr.171","article-title":"Intracerebral Adenosine During Sleep Deprivation: A Meta-Analysis and New Experimental Data","volume":"16","author":"Leenaars","year":"2018","journal-title":"J. Circadian Rhythm."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1038\/s41598-017-02505-6","article-title":"Perivascular AQP4 dysregulation in the hippocampal CA1 area after traumatic brain injury is alleviated by adenosine A2A receptor inactivation","volume":"7","author":"Zhao","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"10067","DOI":"10.1523\/JNEUROSCI.6730-10.2011","article-title":"Arousal effect of caffeine depends on adenosine A2A receptors in the shell of the nucleus accumbens","volume":"31","author":"Lazarus","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/php.12864","article-title":"Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation","volume":"94","author":"Hamblin","year":"2018","journal-title":"Photochem. Photobiol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1364\/BOE.10.004003","article-title":"Pilot study of transcranial photobiomodulation of lymphatic clearance of beta-amyloid from the mouse brain: Breakthrough strategies for non-pharmacologic therapy of Alzheimer\u2019s disease","volume":"10","author":"Zinchenko","year":"2019","journal-title":"Biomed. Opt. Express"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1364\/BOE.383390","article-title":"Photobiomodulation of lymphatic drainage and clearance: Perspective strategy for augmentation of meningeal lymphatic functions","volume":"11","author":"Abdurashitov","year":"2020","journal-title":"Biomed. Opt. Express"},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Salehpour, F., Khademi, M., Bragin, D.E., and DiDuro, J.O. (2022). Photobiomodulation Therapy and the Glymphatic System: Promising Applications for Augmenting the Brain Lymphatic Drainage System. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23062975"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1177\/0271678X20982388","article-title":"Achieving brain clearance and preventing neurodegenerative diseases\u2014A glymphatic perspective","volume":"41","author":"Kylkilahti","year":"2021","journal-title":"J. Cereb. Blood Flow Metab."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/23\/6964\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:27:07Z","timestamp":1760146027000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/23\/6964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,25]]},"references-count":178,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["jcm11236964"],"URL":"https:\/\/doi.org\/10.3390\/jcm11236964","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,25]]}}}